Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Vaccine Therapy in Treating Patients With Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating vaccine therapy in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy [Phase 2]
Phase 2 trial evaluating pertuzumab with high-dose trastuzumab for HER2-positive metastatic breast cancer with CNS progression after radioth…
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: Schedules of Nab-Paclitaxel in Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating schedules of nab-paclitaxel in metastatic breast cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy [Phase 2]
A Phase 2 trial evaluating palbociclib plus fulvestrant in HR+ HER2-negative locally advanced or metastatic breast cancer after prior CDK4/6…
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors [Phase 1]
Phase I study of lurbinectedin in combination with paclitaxel, with or without bevacizumab, in selected advanced solid tumors (completed; re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency [Phase 2]
Phase 2 trial comparing paclitaxel and olaparib versus paclitaxel/carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant therapy…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Exemestane and Cyclophosphamide for Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating exemestane and cyclophosphamide for metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy [Phase 3]
Phase 3 clinical trial update for NX in luminal B breast cancer patients after neoadjuvant chemotherapy.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 safety study evaluating chemotherapy combined with a dendritic cell vaccine in breast cancer patients; results posted …
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Study to Investigate the Effect of AB-101 in Breast Cancer Survivors [EARLY_Phase 1]
Early-phase study investigating AB-101 in breast cancer survivors; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients [Phase 3]
Phase 3 trial comparing neoadjuvant aromatase inhibitor with ovarian suppression versus chemotherapy in premenopausal breast cancer; study t…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Multi-Media Imagery Program for Breast Cancer Patients (Phase II) [Phase 2]
Phase II clinical trial update for a multi-media imagery program in breast cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without colony-stimulating factors for breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant Chemotherapy [Phase 2]
Phase 2 trial evaluating vinorelbine plus capecitabine with trastuzumab for HER2-positive breast cancer after neoadjuvant chemotherapy; stat…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: 12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER) [Phase 2]
A Phase 2 trial update investigating 12 weeks of docetaxel plus trastuzumab in small, node-negative, HER2-positive breast cancer (SOBER). St…
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor. [Phase 2]
Phase 2 clinical trial evaluating estramustine for breast cancer progression after aromatase inhibitor therapy has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions [NA]
Clinical trial PORTAL reports patient-reported outcomes after routine treatment of atypical breast lesions; results were posted in March 202…
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo [NA]
A terminated clinical trial evaluating PET/MR imaging for surgical planning in breast cancer patients treated with neoadjuvant chemotherapy;…
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer [EARLY_Phase 1]
Early-phase trial investigating Abraxane combined with lapatinib in stage I–III breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx [Phase 1]
Phase 1 trial updating BYL719 (alpelisib) plus T-DM1 in HER2-positive metastatic breast cancer patients who progressed on trastuzumab and ta…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors [Phase 3]
A Phase 3 clinical trial update examining how obesity affects the efficacy of endocrine therapy with aromatase inhibitors in breast cancer p…
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate [Phase 2]
Phase 2 clinical trial evaluating eribulin mesylate for brain metastases from metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy [Phase 2]
Phase 2 trial evaluating a mindfulness-based intervention for breast cancer patients undergoing chemotherapy has been completed.
-
CLINICAL_TRIALS trial_result · 2020-03-02Clinical Trial Update: Impact of the Serratus Plane Block in Pain and the Use of Opioids in Breast Surgery [Phase 4]
Phase 4 trial update evaluating the impact of serratus plane block on pain and opioid use in breast surgery.
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen [Phase 1]
Phase 1 dose-escalation study in female breast cancer patients on aromatase inhibitor or tamoxifen; results completed with posted results.